Event Brief
FDA Questions Leucovorin's Efficacy for Autism
Filed: Mar 10, 2026 at 1:06 PM ET
Summary: FDA finds limited evidence supporting leucovorin for autism, approving it only for a rare genetic disorder.
WHO: FDA
WHAT: Approved leucovorin for a rare brain disorder
WHEN: Mar 10, 2026 at 12:10 PM ET
WHERE: Washington
WHY: To clarify the drug's use amid claims of its efficacy for autism
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →